PHE, in partnership with Cancer Research UK, have published new data showing how chemotherapy, radiotherapy and surgery rates vary for different groups of patients in England.
Anna is a cancer data analyst on the partnership between Cancer Research UK and Public Health England, working with data from PHE’s National Cancer Registration and Analysis Service (NCRAS). Her current work concentrates on understanding cancer treatment variation in England. She joined the partnership in 2015, following a Masters in Global Health Science at the University of Oxford.
Related content and links
About this blog
The official blog of the UK Health Security Agency, providing expert insight on the organisation's work and all aspects of health security.
Comments and moderation
- Charting a course to end HIV transmission in England by 2030 1 December 2021
- What is avian flu? 26 November 2021
- What is antimicrobial resistance and why do we need to take action against it? 17 November 2021